About: http://data.cimple.eu/news-article/1d8475ae9d5afa8510910fc7c66b5aa91936d9f9bca97d175c5e5fbc

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: http://data.cimple.eu/news-article/1d8475ae9d5afa8510910fc7c66b5aa91936d9f9bca97d175c5e5fbc Goto Sponge NotDistinct Permalink

An Entity of Type : schema:NewsArticle, within Data Space : data.cimple.eu associated with source document(s)

Attributes	Values
rdf:type	schema:NewsArticle
schema:articleBody	French pharma group Sanofi is "proud" of the solidarity it has shown in agreeing to help produce 125 million doses of the Covid-19 vaccine developed by rivals Pfizer-BioNTech, a senior executive said Wednesday. Sanofi announced on Tuesday that it will use its factory in Frankfurt, Germany, for a rare act of cooperation in an industry usually marked by cut-throat competition. After its own vaccine candidate based on an existing flu jab failed to produce results in December, the group began looking at how it could work with competitors, head of Sanofi France Olivier Bogillot said. "We looked at how we could show solidarity," he told RTL radio, adding: "When you look at the technological and industrial capacities of Sanofi, our expertise, I'm very proud that Sanofi has made this choice." The jabs would be ready from the middle of the year and be distributed in the European Union, he said. The group has been fiercely criticised by some politicians in France over planned job cuts, while others have expressed dismay over the country's failure to produce its own Covid-19 vaccine. The Paris-based Pasteur Institute announced on Monday that its vaccine candidate based on a measles jab had also been abandoned. Bogillot said that talk of France's scientific "decline" was overblown and that Sanofi was continuing to develop another two vaccine candidates. "There are 200 to 250 groups of researchers working on a vaccine and there were maybe 300 at the start. Around 10 percent of them will manage to produce a vaccine," he explained. "Sanofi will be among this 10 percent and maybe we'll have two." Bogillot also said that the European Union had fallen behind the United States, China and neighbour Britain. "Europe has fallen behind on life sciences. This crisis shows how life sciences, biology and biotechnology are a strategic sector," he said. "We need more public and private investment... France has everything going for it to succeed." adp/cb/bmm
schema:headline	Sanofi 'proud' to help make rivals' vaccines
schema:mentions	Biotechnology Biology Frankfurt Industry Measles RTL Group Jab Germany Influenza European Union France Vaccine United States China Coronavirus disease 2019 Pasteur Institute Citizens band radio Sanofi Adenosine diphosphate
schema:author	http://data.cimple.eu/organization/1f0054d541e000623a2c1e561a247c073ef6328e8be9ffafda7b3fcd
schema:datePublished	2021-01-27 (xsd:date)
http://data.cimple...sPoliticalLeaning	other political leaning
http://data.cimple...logy#hasSentiment	positive sentiment
http://data.cimple...readability_score	68 (xsd:integer)
http://data.cimple...tology#hasEmotion	happiness

Faceted Search & Find service v1.16.115 as of Oct 09 2023

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3238 as of Jul 16 2024, on Linux (x86_64-pc-linux-musl), Single-Server Edition (126 GB total memory, 5 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software